GL1X · GenesisL1 explorer

Research workbench

Small molecule inhibitors of the ledgf site of HIV integrase identified by fragment screening and structure based design.

Analyse Small molecule inhibitors of the ledgf site of HIV integrase identified by… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZCM
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV integrase
EC
2.7.7.-
UniProt
Q76353
Ligands
PX3, SO4
Pockets
7 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV integrase (EC 2.7.7.-)protein14953% helix, 21% strandQ76353

Ligands and binding sites

  • PX3 · 5-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12330.640.8228SO4, ACT
2920.470.8120empty
31120.460.7817PX3
4840.450.8020empty
51230.430.7617PX3

Interfaces

1 interface between chains.

  • A–B · 1493 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 3ZCM · Small molecule inhibitors of the LEDGF site of HIV integrase identified by fragment… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.